Latest News about NVO
Recent news which mentions NVO
This Healthcare Stock's Bad News Could Create a $10 Billion Opportunity for Competitors
August 17, 2025
From Motley Fool
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Eli Lilly Strikes $1.3 Billion Deal With Superluminal To Develop AI-Driven Obesity Drugs
August 15, 2025
From Benzinga
From Benzinga
From Motley Fool
Best Stock to Buy: Novo Nordisk Stock vs. UnitedHealth Stock
August 14, 2025
From Motley Fool
Why Novo Nordisk Stock Topped the Market Today
August 13, 2025
From Motley Fool
Why Eli Lilly Stock Popped Today
August 13, 2025
From Motley Fool
Weighing The Costs: Obesity Drug Users Make Financial Sacrifices As Coverage Tightens
August 13, 2025
From Benzinga
How Novo Nordisk's Weight-Loss Drug Could Unlock A Better Future For Biogen's Alzheimer's Treatment
August 13, 2025
From Benzinga
The 3 Things That Matter for Viking Therapeutics Now
August 13, 2025
From Motley Fool
From Benzinga
UK Government, Eli Lilly Partner To Target Obesity Health Gaps
August 12, 2025
From Benzinga
Best Stock to Buy: Eli Lilly Stock vs. Novo Nordisk Stock
August 12, 2025
From Motley Fool
Novo Nordisk Stock: Buy or Sell?
August 12, 2025
From Motley Fool
Sanofi, Eli Lilly, Novo Nordisk, AstraZeneca Face Renewed Claims Of Conspiring To Restrict 340B Discounts
August 11, 2025
From Benzinga
4 of the Most Undervalued Stocks in the Market Right Now
August 11, 2025
From Motley Fool
From Motley Fool
From TalkMarkets
Why Hims & Hers Stock Sank This Week
August 09, 2025
From Motley Fool
Why Novo Nordisk Stock Flew Higher on Friday
August 08, 2025
From Motley Fool
From TalkMarkets
Novo Nordisk Is Down 70%: Is the Price Too Low To Ignore?
August 08, 2025
Tickers
NVO
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.